One-Liner
Use Foundayo (oral GLP-1 pill, no refrigeration needed) to enable US patients to get weight-loss prescriptions from Mexican telehealth doctors at 30-50% of US wholesale cost.
AI Thinking Process
Impossibility Negation: oral GLP-1 removes cold-chain barrier. Mexican prescribers can prescribe orforglipron at 30-50% of US wholesale. FDA personal-importation policy allows 90-day supply.
But this helps consumers evade FDA pharmacy regulation. Liability: bad batch, mislabeled dose. DOJ action against import broker ends company.
Killed — regulatory risk is fundamental, not positional. Broker-in-the-value-chain = enforcement target regardless of pivot framing.
Kill Reason
Fundamental regulatory risk: FDA and Customs enforcement targets import brokers directly. A DOJ action against the broker ends the company. No pivot keeps the broker in the value chain without inheriting the enforcement risk; pivots that remove the broker remove the product.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.